At Jubilant Biosys, our bioanalytical group excels in quantitative LC-MS/MS method development, validation, and study sample analysis. The team has extensive expertise in developing sensitive methods for LC-MS/MS, including analysis of multi-analytes, metabolites, pro-drugs, and photo/temperature sensitive, ex-vivo instable compounds and biomarkers We perform GLP-compliant bioanalysis for regulatory studies and routinely validate methods for new chemical entities in various species. Using advanced technology, our experienced team delivers high-quality data promptly to support drug discovery and development. Our GLP bioanalysis includes method development and validation, sample analysis, and detailed reporting, all adhering to the highest quality standards. By offering both non-GLP and GLP bioanalysis, Jubilant Biosys provides a seamless transition from early-stage research to regulatory approval, supporting our clients in achieving successful drug development outcomes with robust and reliable data.
Compiled from https://www.jubilantbiosys.com
